Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

209
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
209
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

132
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
132
Censoring Survival Data01:09

Censoring Survival Data

167
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
167
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

166
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
166
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

237
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
237
Actuarial Approach01:20

Actuarial Approach

103
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mind the Gap: A Sequential 4-Step Missing Data Management for CGM-Derived Endpoints in Diabetes Clinical Trials.

Journal of diabetes science and technology·2026
Same author

Minimum mortality temperature by cause of death and age group: A multi-country observational study (1990-2019).

Environmental research·2026
Same author

Rooting Nursing Education in Creation Life: A Whole-Person Framework.

Journal of Christian nursing : a quarterly publication of Nurses Christian Fellowship·2026
Same author

Changes in susceptibility to heat on suicide mortality within summer in Japan, 1973-2020: A two-stage time-series analysis.

Psychiatry research·2026
Same author

Heatwaves, Cold Spells, and Renal Disease Mortality in Japan: Vulnerable Populations and Temporal Trends (1979-2019).

Environment & health (Washington, D.C.)·2026
Same author

Rectal-cancer mimic of recurrent high-grade prostate adenocarcinoma.

BMJ case reports·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Aug 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Statistical methods for handling missing data to align with treatment policy strategy.

Yun Wang1, Wenda Tu1, Yoonhee Kim1

  • 1Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.

Pharmaceutical Statistics
|March 27, 2023
PubMed
Summary
This summary is machine-generated.

This study addresses handling missing data in clinical trials for antihyperglycemic drugs. It explores five statistical methods within the treatment policy strategy to ensure accurate treatment effect estimation after intercurrent events.

Keywords:
intercurrent eventsmissing dataretrieved dropoutsreturn-to-baselinetreatment policy strategywashout method

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

630

Related Experiment Videos

Last Updated: Aug 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

630

Area of Science:

  • Clinical Trials Methodology
  • Statistical Analysis in Pharmaceuticals
  • Pharmacometrics

Background:

  • The International Council for Harmonization (ICH) E9(R1) addendum emphasizes pre-trial estimand selection based on study objectives.
  • Intercurrent events, such as treatment modifications, are critical considerations in defining estimands for clinical trials.
  • The treatment policy strategy is commonly used to maintain the integrity of the planned treatment regimen analysis.

Purpose of the Study:

  • To explain methods for handling missing data following intercurrent events in antihyperglycemic product development.
  • To evaluate five distinct statistical imputation methods within the treatment policy framework.
  • To demonstrate the application of these methods in real-world antihyperglycemic drug development.

Main Methods:

  • Application of five statistical imputation methods for missing data after intercurrent events.
  • Utilizing the treatment policy strategy for data analysis.
  • Comparison of imputation methods through Markov Chain Monte Carlo (MCMC) simulations.

Main Results:

  • Five statistical methods were applied to impute missing data under the treatment policy strategy.
  • Markov Chain Monte Carlo simulations were employed to compare the performance of these methods.
  • Three of the evaluated methods were successfully applied to estimate treatment effects for marketed antihyperglycemic agents.

Conclusions:

  • The treatment policy strategy provides a robust framework for handling intercurrent events in clinical trials.
  • The choice of imputation method can significantly impact the estimation of treatment effects.
  • The study validates the practical application of specific imputation techniques in antihyperglycemic drug development.